Reunion Neuroscience Inc
Clinical trials sponsored by Reunion Neuroscience Inc, explained in plain language.
-
Single-Shot anxiety treatment? new drug RE104 heads to trial
Symptom relief Recruiting nowThis study tests whether a single injection of RE104 can reduce anxiety symptoms in 64 adults with Generalized Anxiety Disorder (GAD). Participants will receive either RE104 or a placebo, and their anxiety levels will be measured using a standard scale. The goal is to see if RE10…
Phase: PHASE2 • Sponsor: Reunion Neuroscience Inc • Aim: Symptom relief
Last updated May 26, 2026 10:05 UTC
-
One-Dose hope: new drug targets emotional toll of cancer and chronic disease
Symptom relief Recruiting nowThis study tests whether a single injection of RE104 can reduce depression and anxiety symptoms in people with adjustment disorder caused by cancer, ALS, multiple sclerosis, Parkinson's disease, or idiopathic pulmonary fibrosis. About 100 participants will receive either a higher…
Phase: PHASE2 • Sponsor: Reunion Neuroscience Inc • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC